<DOC>
	<DOCNO>NCT00270816</DOCNO>
	<brief_summary>The therapy Interferon-ß-1b reduces inflammatory component multiple sclerosis positive effect disease course . The 8 MUI dose alternate day keep constant year . About 1/3 patient suspend treatment three year due side effect suspect accepted ineffectiveness . The main objective study verify safety effectiveness cyclical administration ( month suspension two treatment ) begin treatment . There possibility scheme envisage therapy free interval reduce onset negative feedback ( antagonise drug therapeutic effect ) compare standard administration protocol . This might also result increase drug effectiveness and/or longer duration effectiveness . Finally , cyclical administration allow patient spend actual period `` therapeutic vacation '' , positive psychological effect .</brief_summary>
	<brief_title>Interferon ß-1b Treatment Cyclical Administration</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<criteria>Patients affect remit Multiple Sclerosis least relapse last year disease . Satisfying general clinical condition accord researcher . Adequate hepatic function . Capacity use adequate contraceptive technique study . Any disease might better explain sign symptoms patient . Any disability condition might interfere clinical evolution . History hypersensitivity natural recombinant interferon human albumin . Clinically significant heart diseases control like dysrhythmias , angina pectoris congestive heart failure . Not adequately control epilepsy . Inability , accord examine commission , grant complete compliance protocol requirement whole study . Previous therapy modify disease course last six month . Steroid therapy last 3 month . Pregnancy , lactation , serological positivity pregnancy test screening period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Interferon-ß-1b</keyword>
	<keyword>Therapy</keyword>
</DOC>